Sun Pharmaceutical Industries Ltd.

Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that it enclosed details of loss of share certificates/request for issue of duplicate share certificate reported by/ received from shareholders of the Company, received from its Registrar and Transfer Agent, Link Intime India on May 18, 2022.

The above information is a part of company’s filings submitted to BSE.